SCHEMBL23722844

SCHEMBL23722844

N=C(N)NCCNC(=O)c1cc(-c2ccccc2)nc2ccccc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 3/20 0.67
MEN1 O00255 2/20 0.63
KMT2A Q03164 2/20 0.63
CACNA1B Q00975 1/20 0.63
APBA1 Q02410 1/20 0.63
KDM4E B2RXH2 5/20 0.62
LMNA P02545 4/20 0.62
ALDH1A1 P00352 4/20 0.62
RECQL P46063 1/20 0.62
MAPK1 P28482 1/20 0.61
CYP3A4 P08684 1/20 0.60
POLB P06746 1/20 0.59
SMN1; SMN2 Q16637 2/20 0.58
TP53 P04637 3/20 0.57
NPC1 O15118 1/20 0.57
HTT P42858 1/20 0.57
RAB9A P51151 1/20 0.57
PDE10A Q9Y233 1/20 0.57
CYP2C9 P11712 1/20 0.56
MOK Q9UQ07 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23722901 0.86 TACR3 (0.72) TACR3MEN1KMT2ACACNA1BAPBA1
SCHEMBL23722846 0.85 TACR3 (0.70) TACR3MEN1KMT2ACACNA1BAPBA1
SCHEMBL8617743 0.85 CYP3A4 (0.65) TACR3MEN1KMT2AKDM4ELMNA
SCHEMBL23722840 0.84 TACR3 (0.69) TACR3MEN1KMT2ACACNA1BAPBA1
SCHEMBL14582371 0.84 TACR3 (0.72) TACR3MEN1KMT2ACACNA1BAPBA1
Hydrochloric Acid SCHEMBL8620745 0.84 CYP3A4 (0.64) TACR3MEN1KMT2AKDM4ELMNA
SCHEMBL14133006 0.82 TACR3 (0.72) TACR3MEN1KMT2AKDM4ELMNA
SCHEMBL10391576 0.81 TACR3 (0.76) TACR3MEN1KMT2ACACNA1BAPBA1
SCHEMBL6450086 0.81 TACR3 (1.00) TACR3MEN1KMT2ACACNA1BAPBA1
SCHEMBL14970873 0.81 MOK (0.80) TACR3MEN1KMT2ACACNA1BAPBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210244721-A1 SMALL MOLECULE ENTEROVIRUS INHIBITORS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-08-12 US disclosed
US-20210244721-A1 SMALL MOLECULE ENTEROVIRUS INHIBITORS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210244721-A1 SMALL MOLECULE ENTEROVIRUS INHIBITORS AND USES THEREOF AR, KLK3, BRDT TACR3 447/4885MEN1 56/4885KMT2A 917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.